Five‐year outcomes of TOOKAD® (WST‐11) vascular‐targeted photodynamic therapy for low‐risk prostate cancer patients: Insights from a tertiary referral centre
Year: 2025
Type: article
Source: BJUI Compass
DOI: 10.1002/bco2.70106
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,770
OpenAlex ID: W4417445171
